Right ventricle: Wrong targets? Another blow for pharmacotherapy in congenital heart diseases

Circulation

Volumn 127, Issue 3, 2013, Pages 314-316

  Roche, S Lucy ^a   Redington, Andrew N ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

angiotensin converting enzyme inhibitors; congenital heart disease; Editorials; transposition of great vessels

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; RAMIPRIL; VALSARTAN;

CARDIOPULMONARY FUNCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CONGENITAL HEART DISEASE; EDITORIAL; HEART DEATH; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE EJECTION FRACTION; HUMAN; LIFESTYLE MODIFICATION; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; TRICUSPID VALVE REGURGITATION; VENTRICULAR ASSIST DEVICE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; FEMALE; HEART VENTRICLES; HUMANS; MALE; STROKE VOLUME; TETRAZOLES; VALINE;

EID: 84872678913     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.155887     Document Type: Editorial

References (24)

1. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002;106:92-99.
2. Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, Ross RD, Pahl E, Blume ED, Dodd DA, Rosenthal DN, Burr J, LaSalle B, Holubkov R, Lukas MA, Tani LY; Pediatric Carvedilol Study Group. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298:1171-1179.
3. Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation. 1997;96:1507-1512.
4. Giardini A, Lovato L, Donti A, Formigari R, Gargiulo G, Picchio FM, Fattori R. A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle. Int J Cardiol. 2007;114:241-246.
5. Dore A, Houde C, Chan KL, Ducharme A, Khairy P, Juneau M, Marcotte F, Mercier LA. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation. 2005;112:2411-2416.
6. Therrien J, Provost Y, Harrison J, Connelly M, Kaemmerer H, Webb GD. Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. Int J Cardiol. 2008;129:187-192.
7. Teun van der Bom MD, Winter MM, Bourna BJ, Groenink M, Vliegen HW, Pieper PG, van Dijk APJ, Sieswerda GT, Roos-Hesselink JW, Zwin-derman AH, Mulder BJM. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation. 2013;127:322-330.
8. Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation. 2002;105:1189-1194.
9. Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol. 2000;36:255-261.
10. Szymański P, Klisiewicz A, Lubiszewska B, Lipczyńska M, Michałek P, Janas J, Hoffman P. Application of Classic Heart Failure Defnitions of Asymptomatic and Symptomatic Ventricular Dysfunction and Heart Failure Symptoms With Preserved Ejection Fraction to Patients With Systemic Right Ventricles. AJC. 2009; 104:414-418. Available from: http://dx.doi. org/10.1016/j.amjcard.2009.03.057.
11. Moons P, Gewillig M, Sluysmans T, Verhaaren H, Viart P, Massin M, Suys B, Budts W, Pasquet A, De Wolf D, Vliers A. Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium. Heart. 2004;90:307-313.
12. Dos L, Teruel L, Ferreira IJ, Rodriguez-Larrea J, Miro L, Girona J, Albert DC, Gonçalves A, Murtra M, Casaldaliga J. Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart. 2005;91:652-656.
13. Matthys D, De Wolf D, Verhaaren H. Lack of increase in stroke volume during exercise in asymptomatic adolescents in sinus rhythm after intraatrial repair for simple transposition of the great arteries. Am J Car-diol. 1996;78:595-596.
14. Derrick G P, Narang I, White PA, Kelleher A, Bush A, Penny DJ, Redington AN. Failure of stroke volume augmentation during exercise and dobutamine stress is unrelated to load-independent indexes of right ventricular performance after the Mustard operation. Circulation. 2000; 102:III154-III159.
15. Fratz S, Hager A, Busch R, Kaemmerer H, Schwaiger M, Lange R, Hess J, Stern HC. Patients after atrial switch operation for transposition of the great arteries can not increase stroke volume under dobutamine stress as opposed to patients with congenitally corrected transposition. Circ J. 2008;72:1130-1135.
16. Prieto LR, Hordof AJ, Secic M, Rosenbaum MS, Gersony WM. Progressive tricuspid valve disease in patients with congenitally corrected transposition of the great arteries. Circulation. 1998;98:997-1005.
17. Khairy P. Looking ahead: clinical trial design in adult congenital heart disease. Future Cardiol. 2012;8:297-304.
18. Shaddy RE. Paediatric heart failure trials.and tribulations. Cardiol Young. 2007;17:354-355.
19. Lester SJ, McElhinney DB, Viloria E, Reddy GP, Ryan E, Tworetzky W, Schiller NB, Foster E. Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol. 2001;88:1314-1316.
20. Hechter SJ, Fredriksen PM, Liu P, Veldtman G, Merchant N, Freeman M, Therrien J, Benson L, Siu S, Webb G. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol. 2001;87:660-663, A11.
21. Robinson B, Heise CT, Moore JW, Anella J, Sokoloski M, Eshagh-pour E. Afterload reduction therapy in patients following intraatrial baffe operation for transposition of the great arteries. Pediatr Cardiol. 2002;23:618-623.
22. van der Bom, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, Sieswerda GT, Roos-Hesslink JW, Zwindermann AH, Mulder BJM. Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle. Am Heart J. 2010; 160:812-818.
23. Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667-1675.
24. Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE, Gersony WM, Gallagher D, Geva T, Margossian R, McCrindle BW, Paridon S, Schwartz M, Stylianou M, Williams RV, Clark BJ 3rd; Pediatric Heart Network Investigators. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Car-diol. 2008;52:85-98.